标题
Cardiac arrhythmia considerations of hormone cancer therapies
作者
关键词
-
出版物
CARDIOVASCULAR RESEARCH
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2019-01-25
DOI
10.1093/cvr/cvz020
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Are all gonadotrophin-releasing hormone agonists equivalent for the treatment of prostate cancer? A systematic review
- (2018) Eva M. Bolton et al. BJU INTERNATIONAL
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- (2018) Joe-Elie Salem et al. CIRCULATION
- Aromatase inhibitors in premenopausal women with breast cancer: the state of the art and future prospects
- (2018) M. Pistelli et al. Current Oncology
- Hormone receptor–positive, HER2-negative metastatic breast cancer: redrawing the lines
- (2018) A. Matutino et al. Current Oncology
- Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer
- (2018) George S. Tria et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of theα-Subunit of Phosphoinositide 3-Kinase in Heart Increases Late Sodium Current and Is Arrhythmogenic
- (2018) Tao Yang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Testosterone-mediated upregulation of delayed rectifier potassium channel in cardiomyocytes causes abbreviation of QT intervals in rats
- (2018) Kimiko Masuda et al. Journal of Physiological Sciences
- Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanisms
- (2018) Joachim Alexandre et al. PHARMACOLOGY & THERAPEUTICS
- CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunities
- (2018) Filipa Lynce et al. PHARMACOLOGY & THERAPEUTICS
- Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment
- (2018) Hitisha K. Patel et al. PHARMACOLOGY & THERAPEUTICS
- Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA Initiative
- (2018) Zhihua Li et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Association of Oral Contraceptives With Drug-Induced QT Interval Prolongation in Healthy Nonmenopausal Women
- (2018) Joe-Elie Salem et al. JAMA Cardiology
- Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review
- (2018) Anthony Matthews et al. BMJ-British Medical Journal
- Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis
- (2017) Larysa H.M. Rydzewska et al. EUROPEAN JOURNAL OF CANCER
- Response to Letter: “Effects of Testosterone Replacement on Electrocardiographic Parameters in Men: Findings From Two Randomized Trials”
- (2017) Thiago Gagliano-Jucá et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A multiscale computational modelling approach predicts mechanisms of female sex risk in the setting of arousal-induced arrhythmias
- (2017) Pei-Chi Yang et al. JOURNAL OF PHYSIOLOGY-LONDON
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
- (2017) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
- (2017) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations
- (2017) Laura M. Spring et al. ONCOLOGIST
- A mutation in the CACNA1C gene leads to early repolarization syndrome with incomplete penetrance: A Chinese family study
- (2017) Xin Liu et al. PLoS One
- Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardia
- (2017) Nicole Melong et al. Scientific Reports
- Normalization of Testosterone Levels After Testosterone Replacement Therapy Is Associated With Decreased Incidence of Atrial Fibrillation
- (2017) Rishi Sharma et al. Journal of the American Heart Association
- GENomE wide analysis of sotalol-induced IKr inhibition during ventricular REPOLarization, “GENEREPOL study”: Lack of common variants with large effect sizes
- (2017) Joe-Elie Salem et al. PLoS One
- Phase 1 study of abemaciclib, an inhibitor of CDK 4 and 6, as a single agent for Japanese patients with advanced cancer
- (2016) Yutaka Fujiwara et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer
- (2016) Nirmanmoh Bhatia et al. CIRCULATION
- Kcne4 deletion sex- and age-specifically impairs cardiac repolarization in mice
- (2016) Shawn M. Crump et al. FASEB JOURNAL
- Complex Influence of Gonadotropins and Sex Steroid Hormones on QT Interval Duration
- (2016) Guillaume Abehsira et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Definition of First-Line Endocrine Therapy for Hormone Receptor–Positive Advanced Breast Cancer
- (2016) Tomás Reinert et al. JOURNAL OF CLINICAL ONCOLOGY
- Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
- (2016) Hope S. Rugo et al. JOURNAL OF CLINICAL ONCOLOGY
- Arrhythmogenic effect of androgens on the rat heart
- (2016) Mariana Argenziano et al. Journal of Physiological Sciences
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence of steroid hormones on ventricular repolarization
- (2016) Joe-Elie Salem et al. PHARMACOLOGY & THERAPEUTICS
- Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer
- (2016) Sara Campora et al. Translational Oncology
- Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) C. Parker et al. ANNALS OF ONCOLOGY
- Endoxifen, the active metabolite of tamoxifen, inhibits cloned hERG potassium channels
- (2015) Yun Ju Chae et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Aldosterone and testosterone: two steroid hormones structurally related but with opposite electrophysiological properties during myocardial ischemia-reperfusion
- (2015) Joachim Alexandre et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Cytochrome P450 17A1 inhibitor abiraterone attenuates cellular growth of prostate cancer cells independently from androgen receptor signaling by modulation of oncogenic and apoptotic pathways
- (2015) HANNAH GROSSEBRUMMEL et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer
- (2015) Sean O'Farrell et al. JOURNAL OF CLINICAL ONCOLOGY
- Aromatase knockout mice reveal an impact of estrogen on drug-induced alternation of murine electrocardiography parameters
- (2015) Junko Kurokawa et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Short QTc Interval in Males with Klinefelter Syndrome-Influence of CAG Repeat Length, Body Composition, and Testosterone Replacement Therapy
- (2015) INGER NORLYK JØRGENSEN et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- Mechanisms of sex and age differences in ventricular repolarization in humans
- (2014) Jose Vicente et al. AMERICAN HEART JOURNAL
- Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer
- (2014) David R. Ziehr et al. BJU INTERNATIONAL
- Screening for Acute I Kr Block Is Insufficient to Detect Torsades de Pointes Liability
- (2014) Tao Yang et al. CIRCULATION
- Effect of testosterone replacement therapy on cardiac performance and oxidative stress in orchidectomized rats
- (2013) S. M. Eleawa et al. Acta Physiologica
- Toremifene for Breast Cancer: A Review of 20 Years of Data
- (2013) Charles L. Vogel et al. Clinical Breast Cancer
- Testosterone Replacement Therapy Improves QTaVI in Hypogonadal Men with Spinal Cord Injury
- (2013) Michael F. La Fountaine et al. NEUROENDOCRINOLOGY
- Estrogen synthesis and signaling pathways during aging: from periphery to brain
- (2013) Jie Cui et al. TRENDS IN MOLECULAR MEDICINE
- The blockade of angiotensin AT1and aldosterone receptors protects rats from synthetic androgen-induced cardiac autonomic dysfunction
- (2012) S. R. Marques Neto et al. Acta Physiologica
- Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancer
- (2012) A. W. Tolcher et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interaction of gonadal steroids and the glucocorticoid corticosterone in the regulation of the L-type Ca2+ current in rat left ventricular cardiomyocytes
- (2011) M. Wagner et al. Acta Physiologica
- Androgen Deprivation Therapy and the Risk of Coronary Heart Disease and Heart Failure in Patients with Prostate Cancer
- (2011) Elisa Martín-Merino et al. DRUG SAFETY
- Aldosterone promotes atrial fibrillation
- (2011) Jan-Christian Reil et al. EUROPEAN HEART JOURNAL
- Effects of testosterone on the Q-T Interval in older men and older women with chronic heart failure
- (2011) J. B. Schwartz et al. INTERNATIONAL JOURNAL OF ANDROLOGY
- Androgen Deprivation Therapy and Competing Risks
- (2011) William K. Kelly et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical and Biochemical Consequences of CYP17A1 Inhibition with Abiraterone Given with and without Exogenous Glucocorticoids in Castrate Men with Advanced Prostate Cancer
- (2011) Gerhardt Attard et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aromatase inhibitors in men: effects and therapeutic options
- (2011) Willem de Ronde et al. Reproductive Biology and Endocrinology
- Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk
- (2010) Glenn N. Levine et al. CIRCULATION
- Influence of Sex Hormones on Cancer Progression
- (2010) Elizabeth J. Folkerd et al. JOURNAL OF CLINICAL ONCOLOGY
- Chronic treatment with anabolic steroids induces ventricular repolarization disturbances: Cellular, ionic and molecular mechanism
- (2010) Emiliano Medei et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cardiovascular Safety of Degarelix: Results From a 12-Month, Comparative, Randomized, Open Label, Parallel Group Phase III Trial in Patients With Prostate Cancer
- (2010) Matthew R. Smith et al. JOURNAL OF UROLOGY
- Acute Effects of Sex Steroid Hormones on Susceptibility to Cardiac Arrhythmias: A Simulation Study
- (2010) Pei-Chi Yang et al. PLoS Computational Biology
- Effects of Testosterone on Ventricular Repolarization in Hypogonadic Men
- (2009) Beny Charbit et al. AMERICAN JOURNAL OF CARDIOLOGY
- Increased prevalence of prolonged QT interval in males with primary or secondary hypogonadism: A pilot study
- (2009) F. Pecori Giraldi et al. INTERNATIONAL JOURNAL OF ANDROLOGY
- The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer
- (2008) Laurence Klotz et al. BJU INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now